Skip to main content
Log in

Interleukin-6 and acute-phase proteins in head and neck cancer

  • Original Paper
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The acute-phase response is the answer of the organism to a disturbance of its homeostasis and is characterized by dramatic changes in the concentration of some plasma proteins defined as acute-phase proteins. In recent years several data have shown that interleukin-6 (IL-6) is the major inducer of acute-phase protein synthesis in human hepatocytes. Recently, we demonstrated higher IL-6 serum levels in head and neck cancer (HNC) patients than in healthy subjects. In the present study we examined the relationship between levels of IL-6 and of several acute-phase proteins, including C-reactive protein (CRP), α1-antitrypsin (AAT), αl-acid glycoprotein (AAG), haptoglobin (HPT) and fibrinogen. Eighteen patients were studied and had squamous cell carcinoma of the larynx (n = 9), oral cavity (n = 4), oropharynx (n = 3) and hypopharynx (n = 2). Proteins were measured at three time points before and three time points after surgery. Significant (P < 0.0001) relationships were found between IL-6 and CRP (r = 0.69), and fibrinogen (r = 0.51), whereas no correlation was found with AAT (r = 0.13, P = 0.56), AAG (r = 0.38; P = 0.07) and HPT (r = 0.16; P = 0.46). These data strongly suggest that IL-6 may play a key role in acute-phase protein synthesis in HNC and in regulation of the complex host response to malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aoles EW, Hinson A, Chapuls-Cellier C, Arnaud P (1982) Modulation of the immune response by plasma protease inhibitors. Scand J Immunol 15:109–113

    Google Scholar 

  2. Arora P, Miller HC (1978) Alpha-1 antitrypsin is an effector of immunologic states. Nature 274:589–590

    Google Scholar 

  3. Baskies AM, Chretien PB, Weiss JF, Makuch RW, Beveridge RA, Catalona WJ, Spiegel HE (1980) Serum glycoprotein in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer 45:3050–3060

    Google Scholar 

  4. Berek JS, Chung C, Kabli K, Watson JW, Knox RM, Martinez-Mara O (1991) Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 164:1038–1043

    Google Scholar 

  5. Blay JV, Negriev S, Combare V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF, Philip T, Favrot M (1992) Serum level of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 52:3317–3322

    Google Scholar 

  6. Fearon KC, McMillan DC, Preston T, Winstanley FP, Cruickshank AM, Shenkin A (1991) Elevated circulating interleukin-6 is associated with an acute phase response but reduced fixed hepatic protein syntesis in patients with cancer. Ann Surg 213:26–31

    Google Scholar 

  7. Gallo O, Gori AM, Attanasio M, Martini F, Fini-Storchi O, Abbate R (1992) Interleukin-6 serum level and monocyte production in head and neck cancer. Br J Cancer 65:479–480

    Google Scholar 

  8. Gallo O, Bani D, Toccafondi G, Almerigogna F, Fini-Storchi O (1992) Characterization of a novel cell line from pleomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor. Cancer 70:559–568

    Google Scholar 

  9. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon beta-2/B-cell stimulatory factor type 2 share identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute-phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251–7255

    Google Scholar 

  10. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto TA, Heinrich PC (1988) Induction of rat acute-phase proteins by interleukin-6 in vivo. Eur J Immunol 18:717–721

    Google Scholar 

  11. Heinrich PC, Castell JV, Andst T (1990) Interleukin-6 and the acute phase response. Biochem J 265:621–636

    Google Scholar 

  12. Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May L, Huang CM, Rosenberg SA, Lotze MT (1989) IL-6/IFN-beta2 as a circulating hormone: induction by cytokine administration in humans. J Immunol 142:1542–1547

    Google Scholar 

  13. Kirnbauer R, Kock A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA (1989) IFN-beta2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142: 1922–1928

    Google Scholar 

  14. Kishimoto T (1989) The biology of interleukin-6. Blood 74:1–5

    Google Scholar 

  15. reciki T, Leluk M (1992) Acute-phase reactant proteins - an aid to monitoring surgical treatment of laryngeal carcinoma. J Laryngol Otol 106:613–615

    Google Scholar 

  16. Lamat N, Zlontnick AY, Shtiller R, Bar I, Merin G (1992) Serum level of IL-1, IL-6 and TNF in patients undergoing coronary artery by-pass grafts or cholecystectomy. Clin Exp Immunol 89:255–260

    Google Scholar 

  17. Luger TA, Krutmann J, Kirnbauer R, Urbanski R, Schwartz T, Klappacher G, Kock A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB (1989) IFN beta-2/IL-6 augments the activity of human natural killer cells. J Immunol 143:1206–1209

    Google Scholar 

  18. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T (1989) Il-6 functions as an autocrine growth factor in renal carcinomas. FEBS Lett 250:607–610

    Google Scholar 

  19. Mulé JJ, McIntosh JK, Jablons DM, Rosemberg SA (1990) Antitumor activity of recombinant IL-6 in mice. J Exp Med 171:629–636

    Google Scholar 

  20. Nakazaki N (1992) Preoperative and postoperative cytokines in patients with cancer. Cancer 70:709–713

    Google Scholar 

  21. Nishimoto N, Yoshizaki K, Tagon H, Monden M, Kishimoto S, Hirano T, Kishimoto T (1989) Elevation of serum interleukin-6 prior to acute-phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 50:399–401

    Google Scholar 

  22. Petersen CM, Ejlersen E, Moestrup SK, Jensen PH, Sand O, Sottrup-Jensen (1989) Immunosuppressive properties of electrophoretically “slow” and “fast” form α 2-macroglobulin: effects on cell mediated cytotoxicity and (allo-) antigen-induced T cell proliferation. J Immunol 142:629–632

    Google Scholar 

  23. Pordagor A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L (1992) Interleukin-6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52:3679–3686

    Google Scholar 

  24. Revel M (1991) Antitumor potentials of interleukin-6. Interferons Cytokines 19:5–8

    Google Scholar 

  25. Revel M, Chen L, Novivk D, Shulman LM, Gotthelf Y, Cohen B, Raber J, Chebath J, Michalevicz R (1989) The growth-promoting,differentiative and cytostatic properties of interleukin-6. Proc Am Assoc Cancer Res 31:499–500

    Google Scholar 

  26. Takai Y, Wong GG, Clark SC, Bucakoff SJ, Hermann SH (1988) B cell stimulatory factor-2 is involved in in vitro induction of cytotoxic T lymphocytes. J Immunol 140:508–514

    Google Scholar 

  27. Tosato G, Pike S (1988) Interferon Beta2/IL-6 is a costimulant for human T lymphocytes. J Immunol 141:1556–1562

    Google Scholar 

  28. Tritarelli E, Rocca E, Testa U, Boccoli G, Camagna A, Calabresi F, Peschle C (1991) Adoptive immunotherapy with high-dose IL-2: kinetics of circulating progenitors correlation with IL-6, GM-CSF level. Blood 77:741–749

    Google Scholar 

  29. Utsumi K, Takai Y, Tada T, Ohezeki S, Fujiwara H, Hamaoka T (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol 145:397–403

    Google Scholar 

  30. Von Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237–246

    Google Scholar 

  31. Wolf T, Chretien PB, Elias GE, Makuch RW, Baskies AM, Spiegel HE, Weiss JF (1979) Serum glycoproteins in head and neck squamous carcinoma. Am J Surg 138:489–500

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallo, O., Gori, A.M., Attanasio, M. et al. Interleukin-6 and acute-phase proteins in head and neck cancer. Eur Arch Otorhinolaryngol 252, 159–162 (1995). https://doi.org/10.1007/BF00178104

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00178104

Key words

Navigation